Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane and Lyophilization Amniotic Membrane), Application (Surgical Wounds, Ophthalmology, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, and Research Center & Laboratories): Global Opportunity Analysis and Industry Forecast, 2021-2030
The global amniotic membrane market was valued at $1,102.45 million in 2020 and is projected to reach $1,728.05 million by 2030, registering a CAGR of 4.6% from 2021 to 2030.
Amniotic membrane is the inmost layer of the placenta, which includes a thick basement membrane or a tissue and an avascular stromal matrix. This membrane has the ability to promote healing; thus, it is utilized in surgical procedures related to Genito-urinary tract, skin, brain, and head and neck. In addition, amniotic membrane is increasingly used for ocular surface reconstruction, including the treatment of persistent epithelial defects and non-healing corneal ulcers, corneal perforations and descemetoceles, bullous keratopathy, as well as corneal disorders with associated limbal stem cell deficiency.
The major factors that drive the growth of the global amniotic membrane market include rise in amniotic membrane transplantation and rise in awareness and education about the benefits of amniotic membrane transplantation. In addition, technological innovations to develop cost-effective therapies are expected to lead to a paradigm shift in the amniotic membrane market globally. However, lack of healthcare professionals restricts the market growth.
The global amniotic membrane market is segmented on the basis of type of product, application, end user and region. According to product type, the market is divided into cryopreserved amniotic membrane and lyophilization amniotic membrane. On the basis of applications, the market is divided into surgical wounds, ophthalmology, and others. On the basis of end user, the market is divided into hospitals, ambulatory surgical centers, specialized clinics, and research center & laboratories. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include AlloSure, Inc., Amnio Technology, LLC, Applied Biologics LLC, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc, Skye Biologics Inc., and TissueTech, Inc.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided detailed quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the type of products and applications used globally.
Key players and their strategies are provided to understand the competitive outlook of the market.
By Product
Cryopreserved Amniotic Membrane
Lyophilization Amniotic Membrane
By Application
Surgical Wounds
Ophthalmology
Others
By End User
Hospitals
Ambulatory Surgical Centers
Specialized Clinics
Research Centers & laboratories
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY Players
Allosure, Inc.
Amnio Technology, LLC
Applied Biologics LLC
FzioMed, Inc.
Human Regenerative Technologies, LLC
Integra Lifesciences Holdings Corporation
Corza Ophthalmology
MiMedx Group, Inc.
Skye Biologics Inc.
TissueTech, Inc.
- CHAPTER 1:INTRODUCTION
- 1.1.Report Description
- 1.2.Key Market Segments
- 1.3.Key Benefits
- 1.4.Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.CXO Perspective
- CHAPTER 3:MARKET LANDSCAPE
- 3.1.Market Definition and Scope
- 3.2.Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3.Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4.Market Share Analysis/Top Player Positioning
- 3.4.1.Market Share Analysis/Top Player Positioning 2020
- 3.5.Market Dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis
- CHAPTER 4:AMNIOTIC MEMBRANE MARKET, BY PRODUCT TYPE
- 4.1.Market Overview
- 4.1.1Market Size and Forecast, By Product Type
- 4.2.Cryopreserved Amniotic Membrane
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3.Lyophilization Amniotic Membrane
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5:AMNIOTIC MEMBRANE MARKET, BY APPLICATION
- 5.1.Market Overview
- 5.1.1Market Size and Forecast, By Application
- 5.2.Surgical Wound
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3.Opthalomology
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4.Others
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- CHAPTER 6:AMNIOTIC MEMBRANE MARKET, BY END USER
- 6.1.Market Overview
- 6.1.1Market Size and Forecast, By End User
- 6.2.Hospital
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3.Ambulatory Surgical Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4.Specialized Clinics
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5.Research Center And Labs
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- CHAPTER 7:AMNIOTIC MEMBRANE MARKET, BY REGION
- 7.1.Market Overview
- 7.1.1Market Size and Forecast, By Region
- 7.2.North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product Type
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.s. Amniotic Membrane Market
- 7.2.6.1. Market Size and Forecast, By Product Type
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Amniotic Membrane Market
- 7.2.7.1. Market Size and Forecast, By Product Type
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Amniotic Membrane Market
- 7.2.8.1. Market Size and Forecast, By Product Type
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3.Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product Type
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Amniotic Membrane Market
- 7.3.6.1. Market Size and Forecast, By Product Type
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Amniotic Membrane Market
- 7.3.7.1. Market Size and Forecast, By Product Type
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Uk Amniotic Membrane Market
- 7.3.8.1. Market Size and Forecast, By Product Type
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Amniotic Membrane Market
- 7.3.9.1. Market Size and Forecast, By Product Type
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Amniotic Membrane Market
- 7.3.10.1. Market Size and Forecast, By Product Type
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Amniotic Membrane Market
- 7.3.11.1. Market Size and Forecast, By Product Type
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4.Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product Type
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Amniotic Membrane Market
- 7.4.6.1. Market Size and Forecast, By Product Type
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Amniotic Membrane Market
- 7.4.7.1. Market Size and Forecast, By Product Type
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. Australia Amniotic Membrane Market
- 7.4.8.1. Market Size and Forecast, By Product Type
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. India Amniotic Membrane Market
- 7.4.9.1. Market Size and Forecast, By Product Type
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Amniotic Membrane Market
- 7.4.10.1. Market Size and Forecast, By Product Type
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia Pacific Amniotic Membrane Market
- 7.4.11.1. Market Size and Forecast, By Product Type
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5.LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product Type
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Amniotic Membrane Market
- 7.5.6.1. Market Size and Forecast, By Product Type
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa, Amniotic Membrane Market
- 7.5.7.1. Market Size and Forecast, By Product Type
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Amniotic Membrane Market
- 7.5.8.1. Market Size and Forecast, By Product Type
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Amniotic Membrane Market
- 7.5.9.1. Market Size and Forecast, By Product Type
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8:COMPANY PROFILES
- 8.1.Allosure, Inc
- 8.1.1.Company Overview
- 8.1.2.Key Executives
- 8.1.3.Company snapshot
- 8.1.4.Operating business segments
- 8.1.5.Product portfolio
- 8.1.6.Business Performance
- 8.1.7.Key Strategic Moves and Developments
- 8.2.Amnio Technology, LLC
- 8.2.1.Company Overview
- 8.2.2.Key Executives
- 8.2.3.Company snapshot
- 8.2.4.Operating business segments
- 8.2.5.Product portfolio
- 8.2.6.Business Performance
- 8.2.7.Key Strategic Moves and Developments
- 8.3.Applied Biologics LLC
- 8.3.1.Company Overview
- 8.3.2.Key Executives
- 8.3.3.Company snapshot
- 8.3.4.Operating business segments
- 8.3.5.Product portfolio
- 8.3.6.Business Performance
- 8.3.7.Key Strategic Moves and Developments
- 8.4.FzioMed Inc
- 8.4.1.Company Overview
- 8.4.2.Key Executives
- 8.4.3.Company snapshot
- 8.4.4.Operating business segments
- 8.4.5.Product portfolio
- 8.4.6.Business Performance
- 8.4.7.Key Strategic Moves and Developments
- 8.5.Human Regenerative Technologies, LLC
- 8.5.1.Company Overview
- 8.5.2.Key Executives
- 8.5.3.Company snapshot
- 8.5.4.Operating business segments
- 8.5.5.Product portfolio
- 8.5.6.Business Performance
- 8.5.7.Key Strategic Moves and Developments
- 8.6.Integra Lifesciences Holdings Corporation
- 8.6.1.Company Overview
- 8.6.2.Key Executives
- 8.6.3.Company snapshot
- 8.6.4.Operating business segments
- 8.6.5.Product portfolio
- 8.6.6.Business Performance
- 8.6.7.Key Strategic Moves and Developments
- 8.7.Katena, Inc.
- 8.7.1.Company Overview
- 8.7.2.Key Executives
- 8.7.3.Company snapshot
- 8.7.4.Operating business segments
- 8.7.5.Product portfolio
- 8.7.6.Business Performance
- 8.7.7.Key Strategic Moves and Developments
- 8.8.MiMedx Group Inc
- 8.8.1.Company Overview
- 8.8.2.Key Executives
- 8.8.3.Company snapshot
- 8.8.4.Operating business segments
- 8.8.5.Product portfolio
- 8.8.6.Business Performance
- 8.8.7.Key Strategic Moves and Developments
- 8.9.Skye Biologics Inc
- 8.9.1.Company Overview
- 8.9.2.Key Executives
- 8.9.3.Company snapshot
- 8.9.4.Operating business segments
- 8.9.5.Product portfolio
- 8.9.6.Business Performance
- 8.9.7.Key Strategic Moves and Developments
- 8.10.Tissue-Tech Inc
- 8.10.1.Company Overview
- 8.10.2.Key Executives
- 8.10.3.Company snapshot
- 8.10.4.Operating business segments
- 8.10.5.Product portfolio
- 8.10.6.Business Performance
- 8.10.7.Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1.GLOBAL AMNIOTIC MEMBRANE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 2.GLOBAL AMNIOTIC MEMBRANE MARKET FOR CRYOPRESERVED AMNIOTIC MEMBRANE, BY REGION, 2020-2030 ($MILLION)
- TABLE 3.GLOBAL AMNIOTIC MEMBRANE MARKET FOR LYOPHILIZATION AMNIOTIC MEMBRANE, BY REGION, 2020-2030 ($MILLION)
- TABLE 4.GLOBAL AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 5.GLOBAL AMNIOTIC MEMBRANE MARKET FOR SURGICAL WOUND, BY REGION, 2020-2030 ($MILLION)
- TABLE 6.GLOBAL AMNIOTIC MEMBRANE MARKET FOR OPTHALOMOLOGY, BY REGION, 2020-2030 ($MILLION)
- TABLE 7.GLOBAL AMNIOTIC MEMBRANE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
- TABLE 8.GLOBAL AMNIOTIC MEMBRANE MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 9.GLOBAL AMNIOTIC MEMBRANE MARKET FOR HOSPITAL, BY REGION, 2020-2030 ($MILLION)
- TABLE 10.GLOBAL AMNIOTIC MEMBRANE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2030 ($MILLION)
- TABLE 11.GLOBAL AMNIOTIC MEMBRANE MARKET FOR SPECIALIZED CLINICS, BY REGION, 2020-2030 ($MILLION)
- TABLE 12.GLOBAL AMNIOTIC MEMBRANE MARKET FOR RESEARCH CENTER AND LABS, BY REGION, 2020-2030 ($MILLION)
- TABLE 13.GLOBAL AMNIOTIC MEMBRANE MARKET, BY REGION, 2020-2030 ($MILLION)
- TABLE 14.NORTH AMERICA AMNIOTIC MEMBRANE, BY Region, 2020-2030 ($MILLION)
- TABLE 15.NORTH AMERICA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 16.NORTH AMERICA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 17.NORTH AMERICA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 18.U.S. AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 19.U.S. AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 20.U.S. AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 21.CANADA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 22.CANADA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 23.CANADA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 24.MEXICO AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 25.MEXICO AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 26.MEXICO AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 27.EUROPE AMNIOTIC MEMBRANE, BY Region, 2020-2030 ($MILLION)
- TABLE 28.EUROPE AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 29.EUROPE AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 30.EUROPE AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 31.GERMANY AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 32.GERMANY AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 33.GERMANY AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 34.FRANCE AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 35.FRANCE AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 36.FRANCE AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 37.UK AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 38.UK AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 39.UK AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 40.ITALY AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 41.ITALY AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 42.ITALY AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 43.SPAIN AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 44.SPAIN AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 45.SPAIN AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 46.REST OF EUROPE AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 47.REST OF EUROPE AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 48.REST OF EUROPE AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 49.ASIA-PACIFIC AMNIOTIC MEMBRANE, BY Region, 2020-2030 ($MILLION)
- TABLE 50.ASIA-PACIFIC AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 51.ASIA-PACIFIC AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 52.ASIA-PACIFIC AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 53.JAPAN AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 54.JAPAN AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 55.JAPAN AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 56.CHINA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 57.CHINA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 58.CHINA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 59.AUSTRALIA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 60.AUSTRALIA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 61.AUSTRALIA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 62.INDIA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 63.INDIA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 64.INDIA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 65.SOUTH KOREA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 66.SOUTH KOREA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 67.SOUTH KOREA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 68.REST OF ASIA PACIFIC AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 69.REST OF ASIA PACIFIC AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 70.REST OF ASIA PACIFIC AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 71.LAMEA AMNIOTIC MEMBRANE, BY Region, 2020-2030 ($MILLION)
- TABLE 72.LAMEA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 73.LAMEA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 74.LAMEA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 75.BRAZIL AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 76.BRAZIL AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 77.BRAZIL AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 78.SOUTH AFRICA, AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 79.SOUTH AFRICA, AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 80.SOUTH AFRICA, AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 81.SAUDI ARABIA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 82.SAUDI ARABIA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 83.SAUDI ARABIA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 84.REST OF LAMEA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 85.REST OF LAMEA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 86.REST OF LAMEA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
- TABLE 87.ALLOSURE, INC INC: KEY EXECUTIVES
- TABLE 88.ALLOSURE, INC INC: COMPANY SNAPSHOT
- TABLE 89.ALLOSURE, INC INC: OPERATING SEGMENTS
- TABLE 90.ALLOSURE, INC INC: PRODUCT PORTFOLIO
- TABLE 91.ALLOSURE, INC INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 92.AMNIO TECHNOLOGY, LLC: KEY EXECUTIVES
- TABLE 93.AMNIO TECHNOLOGY, LLC: COMPANY SNAPSHOT
- TABLE 94.AMNIO TECHNOLOGY, LLC: OPERATING SEGMENTS
- TABLE 95.AMNIO TECHNOLOGY, LLC: PRODUCT PORTFOLIO
- TABLE 96.AMNIO TECHNOLOGY, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 97.APPLIED BIOLOGICS LLC: KEY EXECUTIVES
- TABLE 98.APPLIED BIOLOGICS LLC: COMPANY SNAPSHOT
- TABLE 99.APPLIED BIOLOGICS LLC: OPERATING SEGMENTS
- TABLE 100.APPLIED BIOLOGICS LLC: PRODUCT PORTFOLIO
- TABLE 101.APPLIED BIOLOGICS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 102.FZIOMED INC: KEY EXECUTIVES
- TABLE 103.FZIOMED INC: COMPANY SNAPSHOT
- TABLE 104.FZIOMED INC: OPERATING SEGMENTS
- TABLE 105.FZIOMED INC: PRODUCT PORTFOLIO
- TABLE 106.FZIOMED INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 107.HUMAN REGENERATIVE TECHNOLOGIES, LLC: KEY EXECUTIVES
- TABLE 108.HUMAN REGENERATIVE TECHNOLOGIES, LLC: COMPANY SNAPSHOT
- TABLE 109.HUMAN REGENERATIVE TECHNOLOGIES, LLC: OPERATING SEGMENTS
- TABLE 110.HUMAN REGENERATIVE TECHNOLOGIES, LLC: PRODUCT PORTFOLIO
- TABLE 111.HUMAN REGENERATIVE TECHNOLOGIES, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 112.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
- TABLE 113.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
- TABLE 114.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
- TABLE 115.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
- TABLE 116.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 117.KATENA, INC.: KEY EXECUTIVES
- TABLE 118.KATENA, INC.: COMPANY SNAPSHOT
- TABLE 119.KATENA, INC.: OPERATING SEGMENTS
- TABLE 120.KATENA, INC.: PRODUCT PORTFOLIO
- TABLE 121.KATENA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 122.MIMEDX GROUP INC: KEY EXECUTIVES
- TABLE 123.MIMEDX GROUP INC: COMPANY SNAPSHOT
- TABLE 124.MIMEDX GROUP INC: OPERATING SEGMENTS
- TABLE 125.MIMEDX GROUP INC: PRODUCT PORTFOLIO
- TABLE 126.MIMEDX GROUP INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 127.SKYE BIOLOGICS INC: KEY EXECUTIVES
- TABLE 128.SKYE BIOLOGICS INC: COMPANY SNAPSHOT
- TABLE 129.SKYE BIOLOGICS INC: OPERATING SEGMENTS
- TABLE 130.SKYE BIOLOGICS INC: PRODUCT PORTFOLIO
- TABLE 131.SKYE BIOLOGICS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 132.TISSUE-TECH INC: KEY EXECUTIVES
- TABLE 133.TISSUE-TECH INC: COMPANY SNAPSHOT
- TABLE 134.TISSUE-TECH INC: OPERATING SEGMENTS
- TABLE 135.TISSUE-TECH INC: PRODUCT PORTFOLIO
- TABLE 136.TISSUE-TECH INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1.GLOBAL AMNIOTIC MEMBRANE MARKET SEGMENTATION
- FIGURE 2.GLOBAL AMNIOTIC MEMBRANE MARKET
- FIGURE 3.SEGMENTATION AMNIOTIC MEMBRANE MARKET
- FIGURE 4.TOP INVESTMENT POCKET IN AMNIOTIC MEMBRANE MARKET
- FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
- FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
- FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
- FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
- FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
- FIGURE 11.LOW THREAT OF SUBSTITUTION
- FIGURE 12.HIGH COMPETITIVE RIVALRY
- FIGURE 13.TOP PLAYER POSITIONING, 2020
- FIGURE 14.MARKET SHARE ANALYSIS, 2020
- FIGURE 15.RESTRAINTS AND DRIVERS: AMNIOTIC MEMBRANE MARKET
- FIGURE 16.AMNIOTIC MEMBRANE MARKET SEGMENTATION, BY PRODUCT TYPE
- FIGURE 17.AMNIOTIC MEMBRANE MARKET FOR CRYOPRESERVED AMNIOTIC MEMBRANE, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 18.AMNIOTIC MEMBRANE MARKET FOR LYOPHILIZATION AMNIOTIC MEMBRANE, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 19.AMNIOTIC MEMBRANE MARKET SEGMENTATION, BY APPLICATION
- FIGURE 20.AMNIOTIC MEMBRANE MARKET FOR SURGICAL WOUND, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 21.AMNIOTIC MEMBRANE MARKET FOR OPTHALOMOLOGY, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 22.AMNIOTIC MEMBRANE MARKET FOR OTHERS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 23.AMNIOTIC MEMBRANE MARKET SEGMENTATION, BY END USER
- FIGURE 24.AMNIOTIC MEMBRANE MARKET FOR HOSPITAL, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 25.AMNIOTIC MEMBRANE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 26.AMNIOTIC MEMBRANE MARKET FOR SPECIALIZED CLINICS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 27.AMNIOTIC MEMBRANE MARKET FOR RESEARCH CENTER AND LABS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 28.ALLOSURE, INC INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 29.ALLOSURE, INC INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 30.ALLOSURE, INC INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 31.AMNIO TECHNOLOGY, LLC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 32.AMNIO TECHNOLOGY, LLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 33.AMNIO TECHNOLOGY, LLC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 34.APPLIED BIOLOGICS LLC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 35.APPLIED BIOLOGICS LLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 36.APPLIED BIOLOGICS LLC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 37.FZIOMED INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 38.FZIOMED INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 39.FZIOMED INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 40.HUMAN REGENERATIVE TECHNOLOGIES, LLC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 41.HUMAN REGENERATIVE TECHNOLOGIES, LLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 42.HUMAN REGENERATIVE TECHNOLOGIES, LLC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 43.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES, 2018-2020 ($MILLION)
- FIGURE 44.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 45.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 46.KATENA, INC.: NET SALES, 2018-2020 ($MILLION)
- FIGURE 47.KATENA, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 48.KATENA, INC.: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 49.MIMEDX GROUP INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 50.MIMEDX GROUP INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 51.MIMEDX GROUP INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 52.SKYE BIOLOGICS INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 53.SKYE BIOLOGICS INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 54.SKYE BIOLOGICS INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 55.TISSUE-TECH INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 56.TISSUE-TECH INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 57.TISSUE-TECH INC: REVENUE SHARE, BY REGION, 2020 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook